This virus is the most common cause of membrano-proliferative glomerulonephritis. People with inosine triphosphatase deficiency are protected against the hemolytic anemia caused by the main drug used to treat it, which is an inhibitor of IMP dehydrogenase. Boceprivir and telepravir were recently approved to treat this virus
This virus is the most common cause of membrano-proliferative glomerulonephritis. People with inosine triphosphatase deficiency are protected against the hemolytic anemia caused by the main drug used to treat it, which is an inhibitor of IMP dehydrogenase. Boceprivir and telepravir were recently approved to treat this virus, the most favorable genotypes of which are 2A and 2B. Its genome contains a eIF3 and 40S-subunit binding internal ribosome entry site. The normal regimen to treat it is pegylated interferon and ribavirin, and this virus causes fibrosis and scarring of its target organ. This member of the family flaviviridae is the most commonly transmitted virus in blood transfusions, and is transmitted through injection drug use, sex work, or tattooing. It has no vaccine, and unlike its related A and B types most often establishes a chronic infection, causing cirrhosis and hepatocellular carcinoma. For 10 points, name this virus that causes hepatitis.
This virus is the most common cause of membrano-proliferative glomerulonephritis.
Hepatitis C virus or HCV (prompt on partial)